French law disallows 'generic' biosimilars
The French Parliament has adopted legislation which prevents biosimilar medicinal products from being classed as generics and bans the automatic substitution of one biological medicine for another.
News & Analysis on the Clinical Development and Manufacture of Large Molecule Drugs